Cancer Trials Support Unit
The IDIQ contract number 75N91022D00012 was awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to PPD DEVELOPMENT LP for the Cancer Trials Support Unit (CTSU). The contract provides support for Project Kick-off Meeting/Transition Activities and Electronic Patient-Reported Outcomes (PROs) with a maximum value of $548 million if all options are exercised. The base award amount was $548 million for services to be provided over the period of performance.
75N91021R00021 Department of Health and Human Services National Institutes of Health National Cancer Institute
Award Notice 3/7 7/28/22, 9:31 AM Cancer Trials Support Unit
The National Cancer Institute seeks to award an indefinite delivery/indefinite quantity multiple award contract to provide broad-based, centralized, and fully integrated operational, administrative, regulatory, information technology, and logistical support services to support participation in multi-institutional cancer trials led by NCI-supported clinical trial organizations. Support will be provided under six task areas and will require demonstrated experience in oncology clinical research, clinical trial operations, and information technology systems. Proposals are due by October 1, 2021 and awards are anticipated to have a period of performance from August 1, 2022 through July 31, 2032.
Task areas three, five, and six are partially set aside for small businesses. NAICS codes relevant to the procurement include 541715 and 541712. PSC codes include R425 and R499. The incumbent contractors are Westat, Inc., PPD, and Technical Resources Inc. It is anticipated that the base contract for task area two will be to a single contractor, while multiple contractors may be awarded task areas three through six. The combined value of all task orders issued against all IDIQ contracts is not expected to exceed $500M over the 10-year ordering period.
75N91021R00021 Department of Health and Human Services National Institutes of Health National Cancer Institute
Pre-Solicitation 1/7 9/10/21, 6:10 PM Cancer Trials Support Unit
This solicitation seeks proposals for a Cancer Trials Support Unit to provide support services to the National Cancer Institute's clinical cancer research efforts. Offerors must have experience with patient recruitment support, data management, regulatory support, and other administrative functions to assist researchers conducting clinical cancer research studies. Proposals will be evaluated based on technical approach, management approach, and price/cost. Any questions regarding the RFP are due by October 15, 2021, with proposals due November 15, 2021.
The opportunity is partially set aside for small businesses. Relevant NAICS codes include 541715 and PSC code R425. The incumbent contractor is Westat, Inc. The single-award IDIQ contract has a 5-year period of performance across six task areas in support of NCI clinical trials sites throughout the United States. Estimated values range from $50-75M over the life of the contract.
75N91021R00021 Department of Health and Human Services National Institutes of Health National Cancer Institute
Solicitation 2/7 9/29/21, 9:23 AM Cancer Trials Support Unit
EDJ Associates, Inc. was awarded a $548 million indefinite-delivery/indefinite-quantity (IDIQ) contract from the National Cancer Institute, part of the National Institutes of Health within the Department of Health and Human Services. The contract provides cancer trials support unit services including project kick-off meeting/transition activities and awareness, education, and training. With a maximum value of $548 million if all options are exercised, the contract was awarded against solicitation number 75N91021R00021 for task areas 1 and 3 of the IDIQ.
75N91021R00021 Department of Health and Human Services National Institutes of Health National Cancer Institute
Award Notice 4/7 7/28/22, 9:32 AM Cancer Trials Support Unit
Essex Management, LLC was awarded a Cancer Trials Support Unit (CTSU) Indefinite Delivery Indefinite Quantity (IDIQ) contract by the National Cancer Institute within the National Institutes of Health, Department of Health and Human Services. The maximum value of the IDIQ contract is $548 million if all options are exercised. Task areas awarded under the contract include project kick-off meeting/transition activities and electronic patient-reported outcomes.
75N91021R00021 Department of Health and Human Services National Institutes of Health National Cancer Institute
Award Notice 5/7 7/28/22, 9:40 AM